The PRIP scheme aims to boost India's pharmaceutical R&D by facilitating applications for innovative med tech.

CAR T-cell therapy, a revolutionary treatment that involves genetically engineering a patient's immune cells to fight cancer, offers hope for patients with certain types of blood cancers.

NEW DELHI: India’s first global CAR T-cell therapy for adult B-cell Non-Hodgkin Lymphoma (B-NHL), a kind of blood cancer that ...

Sickle Cell disease disproportionately affects India’s tribal populations, with complications impacting both children and ...

Stem cell therapy, also known as bone marrow transplantation (BMT), offers a life-saving treatment option. This procedure replaces diseased or damaged cells with healthy stem cells, restoring the ...

Cutting-edge stem cell therapy offers hope for a functional cure for Type 1 diabetes, ... In India, there are more than 8.6 lakh people living with T1D.

Glenmark, the world-renowned drug company, has revealed its intention to launch one of the rare drugs that can aid the treatment of cancer. The drug brand, under its wing, has several other drugs that ...

Our Bureau, Mumbai Wednesday, June 18, 2025, 16:30 Hrs [IST] ...